Almandil NB, Liu Y, Murray ML et al. (2013): Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: A systematic review and meta-analysis. Paediatr Drugs, 15, 139-150.
Braüner JV, Johansen LM, Roesbjerg T et al. (2016): Off-label prescription of psychopharmacological drugs in child and adolescent psychiatry. J Clin Psychopharmacol, 36, 500-507.
Carbon M, Kapoor S, Sheridan E et al. (2015): Neuromotor adverse effects in 342 youth during 12 weeks of naturalistic treatment with 5 second-generation antipsychotics. J Am Acad Child Adolesc Psychiatry, 54, 718-727.e3.